Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $44.4700 (-0.89%) ($44.4000 - $44.4700) on Wed. Jul. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.16% (three month average) | RSI | 62 | Latest Price | $44.4700(-0.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.5% a day on average for past five trading days. | Weekly Trend | HALO declines -0.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(50%) IWM(48%) IWC(45%) IWN(44%) | Factors Impacting HALO price | HALO will decline at least -1.08% in a week (0% probabilities). VIXM(-30%) VXX(-11%) UUP(-10%) GLD(-2%) TLT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.08% (StdDev 2.16%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $44.72 | 5 Day Moving Average | $45.02(-1.22%) | 10 Day Moving Average | $45.48(-2.22%) | 20 Day Moving Average | $44.72(-0.56%) | To recent high | -13.1% | To recent low | 14.5% | Market Cap | $6.078b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |